The receptor activator of nuclear factor- (NF-) κB (RANK); its ligand (RANKL); and the antagonist, osteoprotegerin (OPG); comprise an important cytokine system within the bone microenvironment that can mediate tumor growth. The gene discussed is TNFRSF11B; the disease is neoplasm.